Hui Peng (H Peng)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cardiac Resynchronization Therapy

Randomized Controlled Trial

Age Related Macular Degeneration

Vascular Endothelial Growth Factor

Top Venues

Scientific reports

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Hao Xie, Huan Ju, Jing Lu, Xing Wang, Hui Peng
Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration. Scientific reports 14 (1) (2024)
Hao Xie, Huan Ju, Jing Lu, Xing Wang, Hui Peng
Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration. Scientific reports 14 (1) (2024)
Hao Xie, Huan Ju, Jing Lu, Xing Wang, Hui Peng
Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration. Scientific reports 14 (1) (2024)
Hao Xie, Huan Ju, Jing Lu, Xing Wang, Hui Peng
Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration. Scientific reports 14 (1) (2024)
Jinquan Chen, Long Zhao, Xuanheng Ding, Yan Wen, Lingda Wang, Qinxin Shu, Wenxi Xie, Yanyao Liu, Hui Peng
A β 1-40 Oligomers Trigger Neutrophil Extracellular Trap Formation through TLR4- and NADPH Oxidase-Dependent Pathways in Age-Related Macular Degeneration. Oxidative medicine and cellular longevity 2022 (2022)
Yue Bin, Yanyao Liu, Shaoqiu Jiang, Hui Peng
Elevated YKL-40 serum levels may contribute to wet age-related macular degeneration via the ERK1/2 pathway. FEBS open bio 11 (11) (2021)